FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2061786051> ?p ?o ?g. }

• W2061786051 endingPage "S85" @default.
• W2061786051 startingPage "S79" @default.
• W2061786051 abstract "To treat the coagulopathy of trauma, some have suggested early and aggressive use of cryoprecipitate as a source of fibrinogen. Our objective was to determine whether increased ratios of fibrinogen to red blood cells (RBCs) decreased mortality in combat casualties requiring massive transfusion.We performed a retrospective chart review of 252 patients at a U.S. Army combat support hospital who received a massive transfusion (>or=10 units of RBCs in 24 hours). The typical amount of fibrinogen within each blood product was used to calculate the fibrinogen-to-RBC (F:R) ratio transfused for each patient. Two groups of patients who received either a low (<0.2 g fibrinogen/RBC Unit) or high (>or=0.2 g fibrinogen/RBC Unit) F:R ratio were identified. Mortality rates and the cause of death were compared between these groups, and logistic regression was used to determine if the F:R ratio was independently associated with survival.Two-hundred and fifty-two patients who received a massive transfusion with a mean (SD) ISS of 21 (+/-10) and an overall mortality of 75 of 252 (30%) were included. The mean (SD) F:R ratios transfused for the low and high groups were 0.1 grams/Unit (+/-0.06), and 0.48 grams/Unit (+/-0.2), respectively (p < 0.001). Mortality was 27 of 52 (52%) and 48 of 200 (24%) in the low and high F:R ratio groups respectively (p < 0.001). Additional variables associated with survival were admission temperature, systolic blood pressure, hemoglobin, International Normalized Ratio (INR), base deficit, platelet concentration and Combined Injury Severity Score (ISS). Upon logistic regression, the F:R ratio was independently associated with mortality (odds ratio 0.37, 95% confidence interval 0.171-0.812, p = 0.013). The incidence of death from hemorrhage was higher in the low F:R group, 23/27 (85%), compared to the high F:R group, 21/48 (44%) (p < 0.001).In patients with combat-related trauma requiring massive transfusion, the transfusion of an increased fibrinogen: RBC ratio was independently associated with improved survival to hospital discharge, primarily by decreasing death from hemorrhage. Prospective studies are needed to evaluate the best source of fibrinogen and the optimal empiric ratio of fibrinogen to RBCs in patients requiring massive transfusion." @default.
• W2061786051 created "2016-06-24" @default.
• W2061786051 creator A5006627663 @default.
• W2061786051 creator A5007960961 @default.
• W2061786051 creator A5008530627 @default.
• W2061786051 creator A5008609258 @default.
• W2061786051 creator A5017545736 @default.
• W2061786051 creator A5022498185 @default.
• W2061786051 creator A5027352338 @default.
• W2061786051 creator A5050113663 @default.
• W2061786051 creator A5056060130 @default.
• W2061786051 creator A5073322021 @default.
• W2061786051 creator A5082373189 @default.
• W2061786051 creator A5089875347 @default.
• W2061786051 creator A5090188505 @default.
• W2061786051 date "2008-02-01" @default.
• W2061786051 modified "2023-10-17" @default.
• W2061786051 title "The Ratio of Fibrinogen to Red Cells Transfused Affects Survival in Casualties Receiving Massive Transfusions at an Army Combat Support Hospital" @default.
• W2061786051 cites W1603834827 @default.
• W2061786051 cites W1974693697 @default.
• W2061786051 cites W1979769460 @default.
• W2061786051 cites W1980935935 @default.
• W2061786051 cites W1981364809 @default.
• W2061786051 cites W1992034786 @default.
• W2061786051 cites W1996373707 @default.
• W2061786051 cites W1997234893 @default.
• W2061786051 cites W2002079705 @default.
• W2061786051 cites W2009137628 @default.
• W2061786051 cites W2009523497 @default.
• W2061786051 cites W2011356417 @default.
• W2061786051 cites W2024526916 @default.
• W2061786051 cites W2026535276 @default.
• W2061786051 cites W2030577502 @default.
• W2061786051 cites W2033068103 @default.
• W2061786051 cites W2038130486 @default.
• W2061786051 cites W2043953530 @default.
• W2061786051 cites W2048020487 @default.
• W2061786051 cites W2053676833 @default.
• W2061786051 cites W2057902900 @default.
• W2061786051 cites W2069642844 @default.
• W2061786051 cites W2084109452 @default.
• W2061786051 cites W2084280207 @default.
• W2061786051 cites W2085024400 @default.
• W2061786051 cites W2091685079 @default.
• W2061786051 cites W2110820970 @default.
• W2061786051 cites W2113298224 @default.
• W2061786051 cites W2123622204 @default.
• W2061786051 cites W2161194444 @default.
• W2061786051 cites W7852691 @default.
• W2061786051 doi "https://doi.org/10.1097/ta.0b013e318160a57b" @default.
• W2061786051 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18376176" @default.
• W2061786051 hasPublicationYear "2008" @default.
• W2061786051 type Work @default.
• W2061786051 sameAs 2061786051 @default.
• W2061786051 citedByCount "309" @default.
• W2061786051 countsByYear W20617860512012 @default.
• W2061786051 countsByYear W20617860512013 @default.
• W2061786051 countsByYear W20617860512014 @default.
• W2061786051 countsByYear W20617860512015 @default.
• W2061786051 countsByYear W20617860512016 @default.
• W2061786051 countsByYear W20617860512017 @default.
• W2061786051 countsByYear W20617860512018 @default.
• W2061786051 countsByYear W20617860512019 @default.
• W2061786051 countsByYear W20617860512020 @default.
• W2061786051 countsByYear W20617860512021 @default.
• W2061786051 countsByYear W20617860512022 @default.
• W2061786051 countsByYear W20617860512023 @default.
• W2061786051 crossrefType "journal-article" @default.
• W2061786051 hasAuthorship W2061786051A5006627663 @default.
• W2061786051 hasAuthorship W2061786051A5007960961 @default.
• W2061786051 hasAuthorship W2061786051A5008530627 @default.
• W2061786051 hasAuthorship W2061786051A5008609258 @default.
• W2061786051 hasAuthorship W2061786051A5017545736 @default.
• W2061786051 hasAuthorship W2061786051A5022498185 @default.
• W2061786051 hasAuthorship W2061786051A5027352338 @default.
• W2061786051 hasAuthorship W2061786051A5050113663 @default.
• W2061786051 hasAuthorship W2061786051A5056060130 @default.
• W2061786051 hasAuthorship W2061786051A5073322021 @default.
• W2061786051 hasAuthorship W2061786051A5082373189 @default.
• W2061786051 hasAuthorship W2061786051A5089875347 @default.
• W2061786051 hasAuthorship W2061786051A5090188505 @default.
• W2061786051 hasBestOaLocation W20617860511 @default.
• W2061786051 hasConcept C126322002 @default.
• W2061786051 hasConcept C141071460 @default.
• W2061786051 hasConcept C2777396833 @default.
• W2061786051 hasConcept C2778258694 @default.
• W2061786051 hasConcept C2778917026 @default.
• W2061786051 hasConcept C2779036427 @default.
• W2061786051 hasConcept C2779936836 @default.
• W2061786051 hasConcept C2780014101 @default.
• W2061786051 hasConcept C71924100 @default.
• W2061786051 hasConcept C90924648 @default.
• W2061786051 hasConceptScore W2061786051C126322002 @default.
• W2061786051 hasConceptScore W2061786051C141071460 @default.
• W2061786051 hasConceptScore W2061786051C2777396833 @default.
• W2061786051 hasConceptScore W2061786051C2778258694 @default.
• W2061786051 hasConceptScore W2061786051C2778917026 @default.
• W2061786051 hasConceptScore W2061786051C2779036427 @default.

• next